Here, the hypothesis that E2-induced NGB accumulation is a conserved compensatory mechanism important for breast cancer progression, by averting mitochondrial apoptosis, has been evaluated in ERα-expressing breast ductal carcinoma tissue samples with different grades derived from patients who were not subjected to chemotherapy or endocrine treatments earlier. The gene discussed is NGB; the disease is breast ductal adenocarcinoma.